Navigation Links
Novel brain tumor vaccine acts like bloodhound to locate cancer cells
Date:1/5/2012

WINSTON-SALEM, N.C. Jan. 5, 2012 A national clinical trial testing the efficacy of a novel brain tumor vaccine has begun at Wake Forest Baptist Medical Center, the only facility in the Southeast to participate.

The vaccine will be tested in patients with newly diagnosed glioblastoma multiforme (GBM), the most aggressive and highest grade malignant glioma. Wake Forest Baptist will treat a minimum of 25 patients in this randomized, placebo-controlled phase II clinical trial of ICT-107. A total of 20 sites across the country are participating in the trial to test the safety and efficacy of this novel cancer vaccine.

All patients enrolled in the study will receive the current standard treatment for GBM, which includes surgery followed by radiation and chemotherapy. Two thirds of the participants will then also get the experimental vaccine treatment, which will be administered in the post radiation phase of treatment, while the others will get a "dummy," or placebo vaccine in addition to standard therapy.

"This vaccine is for newly-diagnosed patients," said Glenn Lesser, M.D., a professor of internal medicine, hematology-oncology, at Wake Forest Baptist and principal investigator for the study. "Scientifically, it's a very well designed study and we are excited to participate in this clinical trial. We've been asked to participate based on our reputation as an outstanding brain tumor center and the expertise our center has with bringing novel therapies and novel therapeutics to patients."

The approach with this particular vaccine is unique, Lesser added, because it is targeting the antigens or proteins that are present on glioma stem cells, whereas other treatment approaches mostly target differentiated tumor cells.

"The antigens used in this vaccine target the tumor stem cells the handful of cells that keep the tumor alive and dividing. Most of the cells we kill with standard treatment are likely not the ones driving the tumor growth. If the stem cells aren't targeted, they keep generating more tumors."

According to the biotechnology company that is conducting the trial, the Phase I clinical study of ICT-107 in GBM involved 16 newly-diagnosed patients who received the vaccine in addition to standard therapy surgery, radiation and chemotherapy. Those patients demonstrated a one-year overall survival of 100 percent and a two-year survival of 80 percent. Although only a small number of patients were treated, these results compare favorably with historical 61percent one-year and 26 percent two-year survival with standard care alone.

Vaccines for brain tumors are new and experimental, said Lesser, but are gaining more attention in the glioma world.

"Vaccines are a way to harness the body's own defenses which are usually used to ward off or control infections like the flu to fight cancer cells instead," Lesser explained. "It is a way of presenting antigens or proteins normally found on the surface of the cancer cells to the immune system so that immune cells can seek out and kill those cancer cells anywhere in the body. This is not unlike giving a piece of clothing to a bloodhound and then letting it loose to find a missing person."

Wake Forest Baptist is also involved in another brain tumor vaccine trial for patients with low-grade or slower growing gliomas. Among the targets of both of these vaccines is a new protein found on the surface of glioma cells discovered by Waldemar Debinski, M.D., Ph.D, director of the Wake Forest Baptist Brain Tumor Center of Excellence.

"Early studies of vaccines for patients with brain tumors are showing promising results," Lesser said. "We want to help definitively determine how good these novel therapies really are for patients."


'/>"/>

Contact: Bonnie Davis
bdavis@wakehealth.edu
336-716-4977
Wake Forest Baptist Medical Center
Source:Eurekalert

Related medicine news :

1. Novel Hepatitis C Vaccine Shows Some Early Promise
2. BUSM researchers identify novel compound to halt virus replication
3. Novel technique could help boost IVF success and reduce multiple pregnancies
4. Novel export-inhibitor shows promise for treating CLL
5. Novel experimental agent is highly active in CLL patients, interim study shows
6. Researchers identify a novel therapeutic approach for liver cancer
7. Novel drug wipes out deadliest malaria parasite through starvation
8. Novel approach to treating breast cancer shows great promise
9. Wayne State receives $1.9 million from NIH to create novel cystic fibrosis treatments
10. Novel ALS drug slows symptom progression, reduces mortality in phase 2 trial
11. Wayne State University to study novel treatment for antibiotic-resistant bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... West Palm Beach, FL (PRWEB) , ... January 18, 2017 , ... ... April as a fund raiser for Smile Train, an international charity that provides free ... is a hobby of mine and in the past I have run to support ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... Dr. Farhan ... family, cosmetic and implants dentistry. His modern dental practice has two convenient office locations ... a 2017 Top Rated Dentist for the Alexandria area. This award confirms ...
(Date:1/18/2017)... ... 18, 2017 , ... During pregnancy, women are at an ... those dental problems can increase the risk of pregnancy complications. Unfortunately, according to ... to get the dental care they need. Agoura Hills dentist, Philip Shindler ...
(Date:1/17/2017)... ... January 17, 2017 , ... In the crowded Ath-leisure ... a stand-out company for several differences from other mainstream brands. , Firstly, ... this is called 'Agile' manufacturing - http://www.leanproduction.com/agile-manufacturing.html . It allows them to ...
(Date:1/17/2017)... ... 2017 , ... Kevin Harrington (one of the original Sharks from mega-hit reality ... the topic of Beauty and Personal Care. , Everyone makes New ... to commit to these changes than beginning with personal care and beauty products? AsSeenOnTV.pro ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The global CINV drugs market to grow at a ... Thoracic Surgery Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. To ...
(Date:1/18/2017)... JAKARTA, Indonesia , Jan. 17, 2017  With an annual growth ranging from ... for success. CPhI SEA (Jakarta International Expo, March 22-24, 2017) serves the ... What,s new at CPhI SEA 2017? Investment Forum ... Distributors, network Richer conference content Enhanced business ... Reading ...
(Date:1/18/2017)... , Jan. 18, 2017   Seno Medical ... of diagnosing breast cancer through the development of an ... Steve Miller as SVP of Engineering. Mr. ... Realization at FUJIFILM SonoSite, with headquarters in ... majority of his 30-year career to the development of ...
Breaking Medicine Technology: